Where to buy the GLOW Blend.

You can buy the GLOW Blend from research-supply vendors online, the only channel shipping verifiable material. Where to buy GLOW Blend matters more than usual, because one vial holds three compounds: BPC-157, TB-500 and the copper tripeptide GHK-Cu. That means three identity checks, plus a ratio check belonging to blends alone.

GLOW blend

Referenced in this guide

Batch-matched COAHPLC + mass specResearch use only

The GLOW blend referenced throughout this article, supplied as a research compound with a certificate of analysis matched to the lot you receive — the check this site argues you should hold any supplier to.

Shop GLOW blend

• CoA. Certificate of Analysis. A one-page lab report showing a specific lot's identity, purity, and contaminant results. For a blend, it must cover each component separately.
• ISO/IEC 17025. The international quality standard for testing labs. A 17025-accredited lab has been audited by a third party for technical competence.
• Chelate. A metal ion gripped by a molecule at multiple points. GHK-Cu is a copper(II) chelate, meaning the peptide GHK holding one copper ion. That is why copper content is part of its identity.
• ICP-MS. Inductively coupled plasma mass spectrometry. The standard method for measuring elemental metal content. Here it tells you whether the vial really holds the copper the GHK-Cu label implies.
• HPLC. High-performance liquid chromatography. The standard purity test for peptides. For a blend, the method must resolve three different peptides, not report one merged number.
• Lyophilized. Freeze-dried into a stable powder. The GLOW cake is white to pale blue; full color develops on reconstitution.

What is the GLOW Blend, exactly?

The GLOW Blend is not a new molecule. It is three separate syntheses combined into one fill. Each component keeps its own identity, its own CAS number and its own evidence base.

BPC-157 is a synthetic 15-amino-acid peptide, CAS 137525-51-0, taken from a partial sequence of a protein found in human gastric juice. Its proposed mechanism runs through VEGFR2 activation and nitric-oxide signaling, per McGuire and colleagues.

A 2025 systematic review by Vasireddi and colleagues identified 36 studies of BPC-157 for orthopaedic indications. Thirty-five were preclinical. One was clinical.

TB-500 is a marketing name, and that matters at the point of sale. It is sometimes used for full-length thymosin β4, a 43-residue endogenous peptide. Sometimes it means a short synthetic fragment carrying the LKKTETQ actin-binding sequence.

The 2026 Sports Medicine review distinguishes the two, and a 2026 American Journal of Sports Medicine primer treats them as related but distinct.

The parent molecule's biology is genuinely well characterized: 1:1 G-actin sequestration regulating cell motility, as Ying and colleagues set out. Which molecule sits in a given TB-500 vial is exactly what the CoA mass-spec line exists to answer.

GHK-Cu is the copper(II) chelate of glycyl-L-histidyl-L-lysine, a tripeptide your own plasma carries. Levels average 200 ng/mL at age 20 and fall to roughly 80 ng/mL by age 60, per Dou and colleagues.

The histidine residue grips copper with exceptionally high affinity. The chelate, CAS 89030-95-5 at 401.9 g/mol, is the typical bioactive form, and that copper is why authentic solutions carry a faint blue tint.

GHK-Cu is the most widely used dermal peptide in commercial skincare, with decades of topical formulation history. It has essentially no controlled human data for injectable use.

Here is the honest framing for the GLOW combination. The three compounds target complementary repair and remodeling biology, and no controlled human trial has studied the trio together.

The closest published data point is a 2021 retrospective knee-pain case series where just 4 participants received a two-compound BPC-157 and TB-500 co-injection. It was uncontrolled, with telephone-recall follow-up and no isolated efficacy data, per Lee and Padgett. A pre-mix buys you convenience and a fixed ratio. It does not buy combined evidence.

Where can you buy the GLOW Blend?

The GLOW Blend is sold through three channels, and only one of them ships material you can verify. Research-supply vendors are that one. Compounding pharmacies are effectively closed to this trio, and the aesthetics gray market is where documentation is thinnest.

• Research-supply vendors: The only channel with verifiable material. Freeze-dried single-vial pre-mix, laboratory-use labeling, $110-$200 per 70 mg vial.
• Compounding pharmacies: Effectively closed. The FDA put BPC-157 on its Category 2 503A list in 2023, and neither TB-500 nor injectable GHK-Cu has an approved-drug pathway.
• The aesthetics gray market: Influencer storefronts, med-spa back channels, DM sellers. Real, easy to reach, and where the blue-dye counterfeit problem concentrates.

1. Research-supply vendors (the only channel with verifiable material)

Research supply is where legitimate GLOW-type blends live. Freeze-dried single-vial pre-mixes labeled for laboratory research use only, which is legal in the US under research-use framing.

The vendor bar is higher than for a single peptide. The CoA has to do three times the identity work, then add composition and copper assays on top. A blend vendor whose posted CoA looks identical to a single-compound CoA has tested one ingredient at most.

2. Compounding pharmacies (effectively closed for this blend)

A 503A compounding pharmacy can in principle prepare peptides under prescription for one named patient. In practice that channel is shut for the GLOW trio.

In 2023 the FDA placed BPC-157 on its Category 2 list for 503A compounding, flagged for safety risks, which pushed most US compounders away. No thymosin-β4 product is FDA-approved, and injectable GHK-Cu has no approved-drug pathway. A pharmacy-branded "glow injection" deserves more scrutiny, not less.

3. The aesthetics gray market (where the “glow” branding lives)

The word "glow" is doing marketing work here, and it points at something real. This blend is sold hard through skincare-adjacent social commerce: influencer storefronts, med-spa back channels, DM sellers, all on before-and-after imagery.

That market inherits GHK-Cu's decades of topical cosmetic credibility and quietly transfers it to an injectable format the literature doesn't cover. It is also where documentation is thinnest, and where the blue-dye counterfeit problem concentrates. We'd buy on documents, not on aesthetics-market momentum.

Which vendors should be on your GLOW Blend shortlist?

A three-compound vial asks more of a supplier than any single does, which makes the shortlist matter more rather than less. Of the 16 storefronts we checked on 13 August 2026, these six published the most: a third-party certificate that opens, and a lab named on it. The columns describe the supplier rather than its catalog, and a GLOW-type pre-mix is a much rarer listing than a single peptide, so confirm the format before ordering. Pricing across this set is benchmarked on BPC-157, the compound all six carry; no GLOW Blend price was verified across these vendors, so no price column appears here.

Three vendors from the same survey are absent on purpose. Red Rock Peptides advertises “Verified With COAs” and publishes no certificate at all. Limitless Biotech gates every price behind an account, so nothing it offers can be compared against anything. Behemoth Labz does publish, but its newest genuine certificate is dated August 2024. The full ranking, with the price column, is in our comparison of peptide companies. Disclosure: this site earns a commission on purchases made through its links, Peptriva included — which is why every column above is a document you can open or a figure you can load for yourself.

A mixture has no CAS of its own, so the certificate needs three identity lines rather than one: BPC-157 at CAS 137525-51-0, TB-500 at CAS 885340-08-9 with the form named explicitly, and the GHK-Cu component with its own CAS number and a measured elemental-copper figure. A single “identity: pass” for the vial has verified nothing.

What should you check before buying the GLOW Blend?

Check the GLOW Blend for four things. Three separate mass-spec identities. A weight-percent ratio assay. An elemental copper number. And stability data on the mixed cake rather than its ingredients. The standard eight criteria for any peptide vendor apply on top.

1. Three compounds, three identity checks

One mass-spec line cannot identify three molecules. A credible GLOW Blend CoA reports a separate identity confirmation for each component.

BPC-157 near 1419.5. The TB-500 heptapeptide fragment near 889.0, or full-length Tβ4 near 4,963 if that is what the vendor ships. They must say which. And GHK-Cu consistent with its 401.9 g/mol copper complex.

Each line should carry its CAS number: 137525-51-0, 885340-08-9 and 89030-95-5. A blend CoA showing one merged "identity: pass" has verified nothing.

2. Ratio verification, the check unique to blends

The label says 10/10/50. The cake is a uniform powder, and nothing about its appearance tells you the split. Your only evidence is a weight-percent composition assay: roughly 71% GHK-Cu, 15% BPC-157 and 14% TB-500 by mass, each within a stated tolerance.

This matters because the economics invite skew. GHK-Cu is by far the cheapest of the three per milligram, so a careless filler can hit the labeled 70 mg total while shorting the two expensive components. Purity numbers cannot catch that. Only a composition assay can.

3. Copper quantitation, and why the blue tint proves nothing

GHK-Cu is a copper chelate, so elemental copper is part of its identity. Copper is roughly 16% of the GHK-Cu mass, 63.5 of 401.9 g/mol. A 50 mg GHK-Cu component therefore implies about 8 mg of elemental copper in the vial.

An honest blend CoA quantifies that copper by ICP-MS or an equivalent method. Its heavy-metals panel should exclude copper as the active, rather than reporting a meaningless "metals: none detected".

The flip side is the counterfeit vector. Buyers have learned that real GHK-Cu is blue, and dye sellers exploit exactly that. A trace of blue colorant reproduces the look of a copper-peptide solution at essentially zero cost.

Color is chemistry's cheapest attribute to fake. Analytical chemists treat GHK-Cu quantitation as a real measurement problem, not a visual checkbox, as Ogórek and colleagues show. If the copper number isn't on the CoA, the blue in your vial is an assertion rather than evidence.

4. Co-formulation stability, a copper complex sharing a vial with two peptides

A blend inherits the shortest stability profile of its components, and the GLOW Blend combines two fragilities. TB-500 is oxidation-sensitive. The GHK-Cu copper complex is light-sensitive, and copper is itself redox-active chemistry sitting in the same solution as the oxidation-prone peptide.

Ask the vendor two things a single-compound seller never faces. Whether the stated shelf life rests on stability data for the mixed cake rather than the ingredients. And what the in-use window is for reconstituted solution stored cold and dark. A vendor who has characterized their blend answers both without hesitation.

What does the GLOW Blend cost in 2026?

The GLOW Blend costs $110-$200 per 70 mg vial in 2026, against roughly $210-$410 to buy the same three compounds separately. GHK-Cu is a short, cheap tripeptide. BPC-157 and TB-500 are longer syntheses. So most of a 10/10/50 vial's mass is its cheapest ingredient. Benchmarks:

• Components bought separately: BPC-157 10 mg runs $80-$150; TB-500 10 mg runs $90-$180; GHK-Cu 50 mg runs $40-$80. Sum: roughly $210-$410 across three vials.
• 70 mg tri-blend vial, 10/10/50: $110-$200. The discount versus separates reflects one vial, one fill, one QC pass, partly offset by the extra blend assays.
• Multi-vial discounts: 10-20% off on 3-packs at most vendors.

Pricing below $80 per tri-blend vial deserves suspicion, not celebration. The synthesis floor for the two long peptides plus per-component testing leaves no room for a bargain.

The plausible explanations are a skewed ratio heavy on cheap GHK-Cu, skipped purification, or skipped testing. Above roughly $250, you are paying the aesthetics-market "glow" premium rather than chemistry.

Is the GLOW Blend legal to buy?

Yes. The GLOW Blend is legal to buy as research reference material labeled for laboratory use, and illegal to sell for human consumption. None of its three components is an approved injectable drug. Here is the full picture, including the sport question:

• United States (FDA): None of the three components is approved as an injectable drug for any indication, and the combination has no separate regulatory status. The blend is legal to buy and sell as research reference material labeled for laboratory use only; selling it for human consumption is illegal. BPC-157 sits on FDA’s Category 2 list for 503A compounding (flagged for safety risks).
• The cosmetic asterisk: GHK-Cu is a legitimate, long-standing topical cosmetic ingredient (“copper tripeptide-1”) under cosmetic regulations. That status covers creams and serums — it does not transfer one inch toward injectable material, however often aesthetics marketing implies otherwize.
• WADA: TB-500/Tβ4 is prohibited under S2 (peptide hormones, growth factors and related substances). BPC-157 was added under S0 (non-approved substances) effective January 2022, per a 2025 review (Józwiak et al., 2025). GHK-Cu is not explicitly listed — irrelevant in practice, since the blend contains two prohibited components. (WADA Prohibited List for current status.)
• Major sports leagues: BPC-157 and TB-500 are generally prohibited; standard anti-doping panels include Tβ4 detection.

What are the red flags when buying the GLOW Blend?

The GLOW Blend red flag we weigh heaviest is a single-compound CoA presented for a three-compound product. Seven more:

• A single-compound CoA presented for a three-compound product. One mass-spec identity, one purity number, no composition assay — the document doesn't match the product. Most common failure in this category.
• Blue color offered as proof of GHK-Cu. “You can see the copper” is not an assay. Dye reproduces the tint; only mass-spec identity plus elemental copper quantitation (ICP-MS or equivalent) proves the chelate.
• No declared TB-500 form. Fragment or full-length Tβ4 — different molecules, different masses. A vendor who can't say which is in the vial hasn't verified it.
• No composition assay. Without weight-percent numbers per component, a 70 mg cake could be mostly cheap GHK-Cu with token amounts of the expensive peptides — and pass every purity test.
• Aesthetic outcome claims. “Glow from within,” dermal-outcome promises, before-and-after photos. Cosmetic claims for an injectable research compound are both scientifically unsupported (no injectable RCTs) and a marker that the vendor is selling to consumers, not researchers.
• Cosmetic-grade GHK-Cu in an injectable-format product. Cosmetic-ingredient supply chains are not held to injectable-material standards for sterility and endotoxin. The CoA should show endotoxin (LAL) and bioburden results on the finished blend.
• Heavy-metals line that ignores the active. A blend CoA must handle copper explicitly — quantified as the active, excluded from the contaminant panel. A generic “heavy metals: pass” suggests the lab never noticed it was testing a copper compound.
• Priced like a single peptide. Tri-blend testing costs more, not less. A $60 “70 mg blend” is priced below its own synthesis floor.

GLOW Blend

70 mg ≥98% pure each Lyophilized

BPC-157 + TB-500 + GHK-Cu, 70 mg total in a single sterile vial (10/10/50). Per-component identity and HPLC purity, composition assay, endotoxin and bioburden on the finished cake, heavy metals with copper handled as the active. third-party tested reference material; COA with every lot.

Learn more

Frequently asked questions

Is the GLOW Blend legal to buy in the USA?

Yes, as research reference material labeled for laboratory use only. None of the three components is FDA-approved as an injectable drug, and none is a controlled substance. Selling the blend for human consumption is illegal; buying it as research material is not. GHK-Cu’s separate life as a cosmetic ingredient covers topical products only.

Is the blue color proof of real GHK-Cu?

No. Authentic GHK-Cu solutions are faintly blue because of the copper(II) complex, the same physics as blue copper proteins. But blue dye reproduces the look for pennies, and counterfeiters lean on exactly that expectation.

We'd treat color as a consistency check only. Identity lives in the mass-spec line. The copper lives in the ICP-MS number, which should come out near 16% of the GHK-Cu mass.

What should a GLOW Blend CoA show?

A GLOW Blend CoA should show six things. Separate mass-spec identity for each compound, near 1419.5 for BPC-157, near 889.0 for the TB-500 fragment with the form declared, and consistent with 401.9 g/mol for GHK-Cu. Then per-component HPLC purity ≥98%.

Then a weight-percent composition assay confirming the labeled ratio, elemental copper content, endotoxin and bioburden on the finished blend, and the name of the ISO 17025-accredited lab. A one-line "purity: 99%" for a three-peptide vial is a document about a different product.

Is a pre-mixed blend better than three separate vials?

Different, not better. The GLOW pre-mix removes reconstitution steps and locks a fixed 10/10/50 ratio. Separate vials cost more in total, but let you set any ratio, or study one compound alone, which is what most of the actual literature did.

There's no controlled evidence that the combined format outperforms its parts. The combination has never been tested in a controlled human study.

Is the GHK-Cu evidence injectable or topical?

Topical, overwhelmingly. Decades of cosmetic formulation history, replicated in-vitro biology (collagen-fibroblast stimulation, ~49% elastase inhibition (Dymek et al., 2023)), and small controlled topical studies — versus zero PubMed-indexed injectable human RCTs in 2020-2026. Full comparison: GHK-Cu injectable vs topical.

Is the blend banned in sport?

For tested athletes, effectively yes. TB-500/Tβ4 is prohibited under WADA S2, and BPC-157 was added under S0 effective January 2022. GHK-Cu isn’t explicitly listed, but two prohibited components make the blend prohibited material, and Tβ4 detection is part of standard anti-doping panels.

How does the GLOW Blend compare to the two-peptide BPC-157 + TB-500 blend?

The two-peptide blend is the recovery-focused pre-mix. The GLOW Blend adds 50 mg of GHK-Cu on top, which shifts the marketing toward skin and aesthetics and adds copper verification to the CoA workload.

The evidence logic is identical for both: component literatures, no combination trials. Deep dive: the BPC-157 + TB-500 blend guide.